LiveOne, Inc. (LVO): Nasdaq/NYSE listing notice — LiveOne receives Nasdaq delisting notice; expects to regain compliance via appeal and reverse split

LiveOne, Inc.

Received delisting determination on Sept 25, 2025 for failing to meet $1.00 bid price rule by the Sept 24 deadline.
Not eligible for second 180-day extension due to insufficient stockholders' equity for initial listing requirements.
Timely appealed to Nasdaq Hearings Panel on Sept 25, 2025, automatically staying delisting pending hearing.
Effected one-for-ten reverse stock split on Sept 26, 2025; stock continues trading on Nasdaq under symbol 'LVO'.
Intends to present compliance plan at hearing; no assurance of success or continued listing.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

LiveOne, Inc. received a nasdaq delisting notice notice regarding minimum bid price.

Exchange: nasdaq
Notice: delisting notice
Deficiency: minimum bid price

Exact text from the filing

September 25, 2025, the Company received a delist determination letter from the Staff advising the Company that the Staff had determined that the Company did not regain compliance with the Bid Price Rule by the September 24, 2025 deadline, and that the Company was not eligible for a second 180 day extension period due to the Company not meeting the minimum stockholders’ equity initial listing requirement for The Nasdaq Capital Market. Accordingly, unless the Company requested an appeal of this determination by October 2, 2025, the Staff had determined that the Company’s securities will be sche

View on SEC.gov

Browse all listing & compliance notices →

LiveOne, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-094771

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.